RefBan

Referral Banners

Yashi

Wednesday, March 12, 2014

Reuters Health Report

Click to View in Browser
03/12/2014
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
U.S. top court case highlights unsettled science in contraception
NEW YORK (Reuters) - - As the U.S. Supreme Court prepares to hear a religious dispute over the Obamacare contraception mandate, advocates on both sides are trying to set the court straight on the science.
Challenges remain before docs use whole-genome sequencing
NEW YORK (Reuters Health) - Before doctors use technology to evaluate every "letter" in a person's DNA to detect or diagnose medical conditions, several hurdles must be overcome, according to a new study.
Geron says FDA halts testing of lead drug
(Reuters) - Geron Corp said the U.S. Food and Drug Administration had ordered to halt the trials of its cancer drug imetelstat due to concerns of liver damage.
Couples' characteristics may predict condom use
NEW YORK (Reuters Health) - Whether heterosexual couples decide to use condoms during sex may be determined more by the nature of the relationship than by aspects of the individual men or women involved, according to a new Dutch study.
Insurers wary of Obamacare unknowns as they plan for 2015
NEW YORK (Reuters) - U.S. health insurers are struggling to set prices for their Obamacare plans in 2015 and decide which regions to return to before the deadlines for submitting those plans to regulators.
Israel's LabStyle launches mobile phone blood sugar monitor
JERUSALEM (Reuters) - Israeli start-up LabStyle Innovations Corp on Tuesday launched a mobile-phone glucose meter for diabetics to monitor their blood sugar levels.
Bayer's Nexavar misses target in liver cancer trial
FRANKFURT (Reuters) - Germany's Bayer said a final stage Phase III clinical trial of cancer drug Nexavar as an adjuvant therapy for liver cancer did not meet its main target.
Court denies Myriad motion to block rival genetic tests
(Reuters) - Myriad Genetics Inc said a U.S. court denied its motion to temporarily stop rival Ambry Genetics Corp from selling products similar to Myriad's gene-based cancer test, the latest setback for the diagnostics company.
Caring for a spouse tied to older women's wellbeing
NEW YORK (Reuters Health) - Doing chores and errands in the course of caring for a disabled husband makes older women a bit happier than just doing housework for its own sake, a new study finds.
Especially for women, hearing loss linked to depression
NEW YORK (Reuters Health) - Hearing-impaired adults are more likely to be depressed than those with excellent hearing - and than those who are fully deaf -according to a large U.S. survey.
Related Video
Wave carpet delivers power potential to coastal communities
Finnish cars finish life as pots and pans
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
Reuters Business Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments:

Yashi

Chitika